Thrombospondin-1 and transforming growth factor beta-1 upregulate plasminogen activator inhibitor type 1 in pancreatic cancer

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of Gastrointestinal Surgery

• Publication date

  1999-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S1091-255X(99)80058-4PMID 10482694
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Effect of Thrombospondin-1 and TGF-β1 on Pancreatic Cancer Cell Invasion

  1998cited by this paper
• The effect of thrombospondin-1 and TGF-beta 1 on pancreatic cancer cell invasion.

  1998cited by this paper
• Thrombospondin-1 and transforming growth factor-beta l promote breast tumor cell invasion through up-regulation of the plasminogen/plasmin system.

  1997cited by this paper
• Differential regulation of protease and extracellular matrix protein expression by transforming growth factor-beta 1 in non-small cell lung cancer cells and normal human bronchial epithelial cells.

  1997cited by this paper
• Quantification of transforming growth factor-beta in biological material using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct.

  1997cited by this paper
• Effects of transforming growth factor-beta 1 and phorbol ester on PAI-1 and PA genes in human lung cells.

  1997cited by this paper
• Prognostic significance of PAI-1 and uPA in cytosolic extracts obtained from node-positive breast cancer patients

  1997cited by this paper
• Activation of Raf-1 in human pancreatic adenocarcinoma.

  1997cited by this paper
• Inhibition of breast cancer progression by an antibody to a thrombospondin-1 receptor.

  1996cited by this paper
• Thrombospondin-1 (TSP-1) promotes the invasive properties of human breast cancer.

  1996cited by this paper
• Combined overexpression of urokinase, urokinase receptor, and plasminogen activator inhibitor‐1 is associated with breast cancer progression: An immunohistochemical comparison of normal, benign, and malignant breast tissues

  1996cited by this paper
• Regulation of transforming growth factor-beta activation by discrete sequences of thrombospondin 1.

  1995cited by this paper
• Thrombospondin and transforming growth factor‐beta 1 increase expression of urokinase‐type plasminogen activator and plasminogen activator inhibitor‐1 in human MDA‐MB‐231 breast cancer cells

  1995cited by this paper
• Immunohistochemical localization of the plasminogen activator inhibitor‐1 in breast cancer

  1995cited by this paper
• Regulation of Transforming Growth Factor-β Activation by Discrete Sequences of Thrombospondin 1 (*)

  1995cited by this paper
• Proteolysis and invasiveness of brain tumors: Role of urokinase-type plasminogen activator receptor

  1994cited by this paper
• Thrombospondin (TSP) and transforming growth factor beta 1 (TGF-beta) promote human A549 lung carcinoma cell plasminogen activator inhibitor type 1 (PAI-1) production and stimulate tumor cell attachment in vitro.

  1994cited by this paper
• The somatomedin B domain of vitronectin. Structural requirements for the binding and stabilization of active type 1 plasminogen activator inhibitor.

  1994cited by this paper
• Thrombospondin binds and activates the small and large forms of latent transforming growth factor-beta in a chemically defined system.

  1994cited by this paper
• Localization of thrombospondin and its cysteine-serine-valine-threonine-cysteine-glycine-specific receptor in human breast carcinoma.

  1994cited by this paper
• The type 1 repeats of thrombospondin 1 activate latent transforming growth factor-beta.

  1994cited by this paper
• Localization of thrombospondin and its cysteine-serine-valine-threonine-cysteine-glycine-specific receptor in human breast carcinoma.

  1994cited by this paper
• Thrombospondin causes activation of latent transforming growth factor- beta secreted by endothelial cells by a novel mechanism [published erratum appears in J Cell Biol 1993 Sep;122(5):following 1143]

  1993cited by this paper
• Expression of thrombospondin (TSP1) and its receptors (CD36 and CD51) in normal, hyperplastic, and neoplastic human breast.

  1993cited by this paper
• Molecular mechanisms of protease‐mediated tumor invasiveness

  1993cited by this paper
• The effect of thrombospondin on invasion of fibrin gels by human A549 lung carcinoma.

  1993cited by this paper
• Molecular mechanisms of protease-mediated tumor invasiveness.

  1993cited by this paper
• Urokinase and urokinase receptor: A paracrine/autocrine system regulating cell migration and invasiveness

  1993cited by this paper
• Identification and characterization of a tumor cell receptor for CSVTCG, a thrombospondin adhesive domain

  1993cited by this paper
• The plasminogen-plasmin system in malignancy

  1992cited by this paper
• The extracellular regulation of growth factor action.

  1992cited by this paper
• Plasminogen Activator Inhibitor Type 1: Biochemistry and Evidence for Modulation of Fibrinolysis In Vivo

  1992cited by this paper
• Thrombospondin Levels in Patients with Malignancy

  1992cited by this paper
• Growth Factors in the Regulation of Plasminogen-Plasmin System in Tumor Cells

  1991cited by this paper
• Plasminogen Activation by Receptor-Bound Urokinase

  1991cited by this paper
• Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor.

  1991cited by this paper
• Localization of urokinase-type plasminogen activator in stromal cells in adenocarcinomas of the colon in humans.

  1991cited by this paper
• The plasminogen activation system in human colon cancer: messenger RNA for the inhibitor PAI-1 is located in endothelial cells in the tumor stroma.

  1991cited by this paper
• Extracellular matrix regulation of growth factor and protease activity.

  1991cited by this paper
• Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas.

  1991cited by this paper
• The role of urokinase-type plasminogen activator in aggressive tumor cell behavior

  1990cited by this paper
• The urokinase receptor and regulation of cell surface plasminogen activation.

  1990cited by this paper
• Growth factors in the regulation of pericellular proteolysis: a review.

  1989cited by this paper
• The interaction of human platelet thrombospondin with fibrinogen. Thrombospondin purification and specificity of interaction.

  1985cited by this paper

• Good or bad: Paradox of plasminogen activator inhibitor 1 (PAI-1) in digestive system tumors.

  2023cites this paper
• Cancer-Associated Fibroblasts: Mechanisms of Tumor Progression and Novel Therapeutic Targets

  2022cites this paper
• Tumor Microenvironment: Extracellular Matrix Components – Part B

  2020cites this paper
• CD36 and CD97 in Pancreatic Cancer versus Other Malignancies

  2020cites this paper
• Thrombospondin in Tumor Microenvironment.

  2020cites this paper
• Thrombospondin-1 at the crossroads of corpus luteum fate decisions.

  2019cites this paper
• Plasminogen activator inhibitor-1 in cancer research.

  2018cites this paper
• Quantitative and qualitative assessment of aortic structure and function, and elastic fiber ultrastructure in the mouse model of Marfan syndrome

  2017cites this paper
• Desmoplastic Reaction In Pancreatic Ductal Adenocarcinoma

  2016cites this paper
• Ciblage thérapeutique du microenvironnement tumoral : exemple du cancer du pancréas

  2014cites this paper
• Mécanismes de progression des carcinomes de la prostate et recherche de nouveaux facteurs pronostiques

  2013cites this paper
• Targeting the cancer-stroma interaction: a potential approach for pancreatic cancer treatment.

  2012cites this paper
• Type 3 Repeats of Thrombospondin-2 Increases Metastasis in Mouse Colorectal Cancer CT-26 Cells

  2010cites this paper
• The plasminogen activator inhibitor system in colon cancer cell lines is influenced by the CO2 pneumoperitoneum

  2010cites this paper
• Contributions of the Extracellular Matrix to Tumorigenesis

  2010cites this paper
• Is There a Genetic Component Responsible for Hypercoagulation in Pancreatic Cancer Patients ?

  2009cites this paper
• Role of anticoagulation in the management of pancreatic cancer.

  2009cites this paper
• Thrombospondin 2 inhibits metastasis of human malignant melanoma through microenvironment-modification in NOD/SCID/gammaCnull (NOG) mice.

  2009cites this paper
• The role of angiocidin in sarcomas

  2009cites this paper
• 87 – Anti-cancer Property of Epicatechin Gallate in Colon Cancer Cells

  2009cites this paper
• Thrombospondins: from structure to therapeutics

  2008cites this paper
• Coagulation, anticoagulation and pancreatic carcinoma

  2008cites this paper
• Differential involvement of TGF-beta1 in mediating the motogenic effects of TSP-1 on endothelial cells, fibroblasts and oral tumour cells.

  2008cites this paper
• Regulation of Angiogenesis and Tumor Growth by Thrombospondin-1

  2008cites this paper
• Thrombospondin 1 promotes tumor macrophage recruitment and enhances tumor cell cytotoxicity of differentiated U937 cells.

  2008cites this paper
• A role for the mitogen-activated protein kinase kinase kinase 1 in epithelial wound healing.

  2006cites this paper
• A Role for the Mitogen-activated Protein Kinase Kinase Kinase 1 in Epithelial Wound Healing □ D

  2006cites this paper
• Thrombospondin 1: a multifunctional protein implicated in the regulation of tumor growth.

  2004cites this paper
• The Tryptophan-rich Motifs of the Thrombospondin Type 1 Repeats Bind VLAL Motifs in the Latent Transforming Growth Factor-β Complex*

  2004cites this paper
• Growth factor regulation of secreted matrix metalloproteinase and plasminogen activators in prostate cancer cells, normal prostate fibroblasts and normal osteoblasts

  2003cites this paper
• Plasmin/Plasminogen System in Colorectal Cancer

  2002cites this paper
• Thrombospondin-1 expression as a prognostic predictor of pancreatic ductal carcinoma.

  2002cites this paper
• Up-regulation of matrix metalloproteinase 9 by thrombospondin 1 in gastric cancer.

  2002cites this paper
• Suppressor and oncogenic roles of transforming growth factor-beta and its signaling pathways in tumorigenesis.

  2001cites this paper
• The Effect of Thrombospondin-1 and TGF-β1 on Pancreatic Cancer Cell Invasion

  1998cites this paper
• Angiostatin generation by human pancreatic cancer.

  1998cites this paper
• The effect of thrombospondin-1 and TGF-beta 1 on pancreatic cancer cell invasion.

  1998cites this paper